Your Best Stock

Johnson & Johnson JNJ

$270.62
+$1.45 (+0.54%)
Market open · Sep 24, 1:10 pm ET
After hours $268.71 -0.17%
Open$269.50
Prev close$269.17
Day range$269.01 – $275.23
Volume2.31M
Market cap$652.05B
P/E (TTM)31.4
Dividend yield1.94%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$25.31B+6.6% YoY
Operating profit$7.17B+6.9% YoY
Net profit$5.53B-0.1% YoY
Diluted EPS$2.27-0.9% YoY
Free cash flow$7.30B+194.2% YoY
Operating cash flow$8.62B

Revenue, last 8 quarters

$22.5BSep '24$22.5BDec '24$21.9BMar '25$23.7BJun '25$24.0BSep '25$24.6BDec '25$24.1BMar '26$25.3BJun '26

Net profit, last 8 quarters

$2.7BSep '24$3.4BDec '24$11.0BMar '25$5.5BJun '25$5.2BSep '25$5.1BDec '25$5.2BMar '26$5.5BJun '26

Diluted EPS by quarter

1.11Sep '241.41Dec '244.54Mar '252.29Jun '252.12Sep '252.10Dec '252.14Mar '262.27Jun '26

Free cash flow by quarter

$5.7BSep '24$4.8BDec '24$3.4BMar '25$2.5BJun '25$8.0BSep '25$5.5BDec '25$1.5BMar '26$7.3BJun '26

Annual revenue

$82.6BFY20$78.7BFY21$80.0BFY22$85.2BFY23$88.8BFY24$94.2BFY25

Profitability & balance sheet

Gross margin67.9%
Operating margin26.8%
Net margin21.5%
Return on equity25.7%
Return on assets10.7%
Return on invested capital16.0%
Current ratio1.09
Liabilities / assets57.7%
Cash & investments$20.76B
Total debt$49.04B
Net cash (debt)-$28.28B
Free cash flow / sales22.7%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Innovative Medicine$16.38B 64.7%
  • MedTech$8.93B 35.3%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $25.31B $24.06B $94.19B $24.56B $23.99B
Total Operating Revenue $25.31B $24.06B $94.19B $24.56B $23.99B
Cost of Revenue $8.05B $8.11B $30.26B $7.97B $7.30B
Gross Profit $17.26B $15.96B $63.94B $16.60B $16.69B
Operating Expense $10.09B $9.56B $38.34B $11.01B $9.59B
Selling and Admin Expenses $6.43B $6.03B $23.68B $6.75B $5.92B
Research & Development $3.65B $3.53B $14.67B $4.25B $3.67B
Operating Profit $7.17B $6.40B $25.60B $5.59B $7.10B
Net Non-Operating Interest Income (Expense) -$62.00M -$43.00M $85.00M $23.00M -$18.00M
Non-Operating Interest Income $219.00M $229.00M $1.06B $237.00M $227.00M
Non-Operating Interest Expense $281.00M $272.00M $971.00M $214.00M $245.00M
Other Income (Expense) -$365.00M -$362.00M $6.89B -$665.00M $437.00M
Special Income (Charges) -$34.00M -$468.00M $5.49B -$865.00M -$163.00M
-Less:Restructuring and Mergern & Acquisition $34.00M $132.00M $428.00M -$116.00M $163.00M
Other Non-Operating Income (Expenses) -$331.00M $106.00M $1.00B $100.00M $200.00M
Pretax Profit $6.75B $5.99B $32.58B $4.97B $7.49B
Tax $1.21B $755.00M $5.78B -$150.00M $2.34B
Net Profit $5.53B $5.24B $26.80B $5.12B $5.15B
Profit from Continuing Operations $5.53B $5.24B $26.80B $5.12B $5.15B
Net Income to Parent Company $5.53B $5.24B $26.80B $5.12B $5.15B
Net Income to Common Stockholders $5.53B $5.24B $26.80B $5.12B $5.15B
Basic EPS $2.30 $2.17 $11.13 $2.12 $2.14
Diluted EPS $2.27 $2.14 $11.03 $2.10 $2.12
Dividend Per Share $1.34 $1.30 $5.14 $1.30 $1.30
-Less:Other Special Charges $300.00M -$6.00B $900.00M
-Less:Write Off $36.00M
Gain on Sale of Security $400.00M $100.00M $400.00M
-Less:Impairment of Capital Assets $81.00M
Net Income from Discontinuous Operations $0.00
-General & Admin Expense $5.92B

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $201.06B $200.89B $199.21B $199.21B $192.82B
Total Current Assets $59.77B $59.17B $55.62B $55.62B $54.61B
Cash and Cash Equivalents & Short-Term Investments $20.76B $22.05B $20.10B $20.10B $18.56B
-Cash and Cash Equivalents $20.42B $21.69B $19.71B $19.71B $18.23B
-Short Term Investments $336.00M $363.00M $393.00M $393.00M $331.00M
Receivables $19.05B $22.54B $21.33B $21.33B $17.61B
-Accounts Receivable $19.05B $17.72B $17.18B $17.18B $17.61B
Inventory $15.14B $14.58B $14.19B $14.19B $14.15B
Other Current Assets $4.83B $4.29B
Total Non-Current Assets $141.29B $141.72B $143.59B $143.59B $138.21B
Net PPE $23.58B $23.27B $23.17B $23.17B $22.34B
-Gross PPE $55.52B $54.70B $54.36B $54.36B $53.38B
-Accumulated Depreciation -$31.94B -$31.43B -$31.20B -$31.20B -$31.04B
Goodwill and Other Intangible Assets $96.71B $97.62B $99.18B $99.18B $96.79B
-Goodwill $48.48B $48.56B $48.77B $48.77B $48.05B
-Other Intangible Assets $48.23B $49.06B $50.40B $50.40B $48.74B
Non-Current Deferred Assets $6.73B $6.73B $6.87B $6.87B $6.67B
Other Non-Current Assets $14.27B $14.11B $14.37B $14.37B $12.42B
Total Liabilities $116.09B $119.71B $117.67B $117.67B $113.54B
Total Current Liabilities $54.90B $57.72B $54.13B $54.13B $50.87B
Payables $10.27B $11.55B $13.38B $13.38B $11.55B
-Accounts Payable $9.22B $10.46B $11.99B $11.99B $9.63B
-Total Tax Payable $1.05B $1.09B $1.39B $1.39B $1.93B
Current Accrued Expenses $29.45B $25.80B $27.72B $27.72B $28.96B
Short-Term Debt and Capital Lease Obligation $11.69B $17.46B $8.50B $8.50B $6.39B
-Current Debt $11.69B $17.46B $8.50B $8.50B $6.39B
Total Non-Current Liabilities $61.20B $61.99B $63.54B $63.54B $62.67B
Long Term Accounts Payable and Other Payables $485.00M $486.00M $486.00M $486.00M $418.00M
Long Term Debt and Capital Lease Obligation $37.34B $37.53B $39.44B $39.44B $39.41B
-Long Term Debt $37.34B $37.53B $39.44B $39.44B $39.41B
Non-Current Deferred Liabilities $6.61B $7.01B $6.79B $6.79B $5.99B
Employee Benefits $6.66B $6.76B $6.96B $6.96B $6.93B
Other Non-Current Liabilities $10.10B $10.21B $9.87B $9.87B $9.93B
Total Equity $84.97B $81.19B $81.54B $81.54B $79.28B
Stockholders' Equity $84.97B $81.19B $81.54B $81.54B $79.28B
Capital Stock $3.12B $3.12B $3.12B $3.12B $3.12B
-Common Stock $3.12B $3.12B $3.12B $3.12B $3.12B
Additional Paid-In Capital $171.67B $169.16B $168.98B $168.98B $167.28B
Less: Treasury Stock $75.86B $76.26B $75.62B $75.62B $75.89B
Gains/Losses Not Affecting Retained Earnings -$13.95B -$14.83B -$14.93B -$14.93B -$15.24B
-Other Receivables $4.82B $4.15B $4.15B
-Preferred Stock $0.00 $0.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $8.62B $2.51B $24.53B $7.31B $9.17B
Net cash flow from continuing operations $8.62B $2.51B $24.53B $7.31B $9.17B
Net Income from Continuing Operations $5.53B $5.24B $26.80B $5.12B $5.15B
Gain/Loss from Continuing Operations -$55.00M $12.00M -$263.00M -$132.00M -$57.00M
Depreciation & Depletion & Amortization $1.96B $2.00B $7.50B $2.01B $1.78B
Deferred Tax -$479.00M $159.00M $1.54B -$3.68B $2.22B
Other Non-Cash Items $0.00 $2.00M $109.00M $0.00 $17.00M
Change in Working Capital $1.02B -$5.23B -$12.72B $3.60B -$369.00M
-Change in Receivables -$1.35B -$595.00M -$1.78B $391.00M $111.00M
-Change in Inventory -$571.00M -$431.00M -$1.45B -$46.00M -$748.00M
-Change in Payables and Accrued Expense $2.96B -$3.92B $2.38B $1.27B $2.00B
-Change in Other Current Assets $950.00M $349.00M -$6.17B $1.49B -$1.46B
-Change in Other Current Liabilities -$972.00M -$629.00M -$5.70B $499.00M -$270.00M
Net cash flow from investing -$1.11B -$1.04B -$23.59B -$4.49B -$542.00M
Net Cash Flow from Continuing Investing Activities -$1.11B -$1.04B -$23.59B -$4.49B -$542.00M
Net PPE Purchase and Sale -$1.32B -$1.05B -$4.83B -$1.84B -$1.16B
Net Intangibles Purchase and Sale $0.00 $0.00 -$385.00M $0.00 -$16.00M
Net Investment Purchase and Sale $519.00M $65.00M $741.00M $2.31B $589.00M
Net Other Investing Changes -$45.00M -$56.00M -$1.57B -$1.88B $43.00M
Financing Cash Flow -$8.78B $530.00M -$5.54B -$1.37B -$8.93B
Net Cash Flow from Continuing Financing Activities -$8.78B $530.00M -$5.54B -$1.37B -$8.93B
Net Issuance Payments Of Debt -$5.75B $7.21B $9.64B $2.11B -$5.14B
Net Common Stock Issuance -$221.00M -$4.03B -$5.95B -$1.92B -$1.90B
Cash Dividends Paid -$3.23B -$3.13B -$12.38B -$3.13B -$3.13B
Proceeds from Stock Option Exercised $359.00M $1.17B $3.42B $1.59B $1.27B
Net Other Financing Charges $60.00M -$697.00M -$260.00M -$6.00M -$24.00M
Ending Cash Balance $20.42B $21.69B $19.71B $19.71B $18.23B
Net Change in Cash -$1.27B $2.00B -$4.60B $1.46B -$300.00M
Beginning Cash Balance $21.69B $19.71B $24.11B $18.23B $18.58B
Effect of Exchange Rate Changes $5.00M -$25.00M $201.00M $23.00M -$46.00M
Free Cash Flow $7.30B $1.47B $19.31B $5.47B $8.00B
Net Business Purchase and Sale -$17.54B -$3.08B -$1.00M
Scroll to Top